On 14 September 2026, HING YIP HLDGS (00132.HK) announced that Guangdong Lujin Finance Leasing Co., Ltd., a subsidiary of the Company, as lessor, entered into a finance lease with Sheyang County Sewage Treatment Co., Ltd., acquiring ownership of the assets for RMB 20,000,000 (equivalent to approximately HKD 23,380,000) and leasing them back for three years, which constitutes a discloseable transaction under the Listing Rules.
On 14 September 2026, SHENZHEN INT'L (00152.HK) announced that it completed the issue of RMB 1 billion of its 2026 fifth tranche medium-term notes on 14 September 2026, with a coupon rate of 1.65% and a term of five years.
On 14 September 2026, LEADS BIOLABS-B (09887.HK) announced that the Company presented updated Phase II clinical study data for Vilxin® (Opatilimab, PD-L1/4-1BB bispecific antibody) in combination with chemotherapy as first-line treatment for NSCLC in an oral presentation at WCLC 2026; as at 1 July 2026, among 62 efficacy-evaluable patients, the ORR in the overall patient population reached 71.0%, the DCR reached 95.2% and the 6-month PFS rate reached 70.6%.
On 14 September 2026, BANK OF GANSU (02139.HK) announced that, at the board meeting held on the same date, the Board resolved to propose the appointment of Mr. Du Jing as an executive director of the fourth session of the board of directors of the Bank and agreed to appoint him as president of the Bank; both his director and president qualifications are subject to approval by the Gansu Regulatory Bureau of the National Financial Regulatory Administration.
On 14 September 2026, MAOYE INT'L (00848.HK) announced that, in order to devote more time to her personal affairs, Ms. Lu Xiaojuan has resigned as an executive Director of the Company on the same date and will continue to serve as the chief financial officer of the Company.
On 14 September 2026, MAXICITY (02295.HK) announced that, in order to restore the Company's public float, as at 10 September 2026 the Offeror, GreenAir Energy Global Limited, had disposed of a total of 33,980,000 Offer Shares to independent third parties through a placing, representing approximately 8.50% of the total number of issued Shares; immediately after the Placing and as at the date of the announcement, the total number of Shares held by the public was 100,000,000 Shares, representing 25% of the total number of issued Shares, and the minimum public float requirement of 25% under Rule 13.32B(1) of the Listing Rules has been restored.
on September 14, 2026, the three major Hong Kong indices moved mixed, with the Hang Seng Index up 0.45%, the Hang Seng TECH Index down slightly by 0.06%, and the Hang Seng China Enterprises Index up 0.46%. The full-day market turnover was 192.6 billion HKD, Southbound funds saw a net inflow of 4.471 billion HKD.
On 14 September 2026, CR HOLDINGS (01911.HK) announced that China Renaissance Pan Asia Investment Advisory (Beijing) Co., Ltd., an indirect wholly-owned subsidiary of the Company, acted as sole financial adviser to the latest Series B financing of AlphaPai, an artificial intelligence application focused on financial scenarios.
On 14 September 2026, VISION VALUES (00862.HK) issued a profit warning stating that the Group is expected to record a loss attributable to owners of the Company of approximately HKD 437,000,000 to HKD 440,000,000 for the year ended 30 June 2026, compared with a net loss of approximately HKD 56,200,000 for the year ended 30 June 2025.
As of 15:30 on September 14, Global X S&P Crude Oil ETF (03097.HK) rose 1.19% to HKD 10.200, with a turnover of approximately HKD 3.5261 million and assets under management of approximately HKD 120 million.
on 14 September 2026, AI chip stocks traded with volatility while HUA HONG GRACE (01347.HK) weakened. As of 13:58, the company quoted HKD 107.200, down 4.03%.
on 14 September 2026, humanoid robot stocks traded with volatility while XIAOMI-W (01810.HK) strengthened. As of 13:24, the company quoted HKD 27.020, up 2.50%.
The three major Hong Kong stock indices weakened throughout the week of September 7–11, 2026, with the Hang Seng Index down 3.30%, the Hang Seng TECH Index down 5.45% and the Hang Seng China Enterprises Index down 3.61%. while average daily turnover was about HKD 209.6 billion and southbound net buying totalled about HKD 20.1 billion. The Stock Connect eligible securities list adjustment took effect on September 7, with 54 stocks added and 15 removed, and BIDU-W was formally included in Stock Connect, with Citi expecting it to attract about USD 6 billion (about HKD 47 billion) in net new southbound capital over the next 2 to 4 months.
On 14 September 2026, ADICON HOLDINGS (09860.HK) published its 2026 interim report, with revenue of RMB 1,284.8 million for the six months ended 30 June 2026, up 1.1% year on year; gross profit of RMB 487.1 million, up 7.2%, at a 37.9% gross margin; profit for the period of RMB 35.3 million, up 23.4%, of which RMB 32.0 million was attributable to owners of the parent, with basic earnings per share of RMB 0.04; cash and cash equivalents of RMB 870.9 million as at 30 June 2026; and no interim dividend declared.
On 14 September 2026, JINCHUAN INTL (02362.HK) published its 2026 interim report, with revenue of USD 460.2 million for the six months ended 30 June 2026, up 152% year on year; gross profit of USD 167.5 million, profit for the period of USD 61.0 million and profit attributable to shareholders of USD 47.8 million; 36,083 tonnes of copper and 349 tonnes of cobalt sold during the period; bank balances and cash of USD 257.4 million and a gearing ratio of 41.3% as at 30 June 2026; and no interim dividend declared.
On 14 September 2026, IMPACT THERAP-B (07630.HK) published its 2026 interim report, with revenue of RMB 105.2 million for the six months ended 30 June 2026, up 316.8% year on year, including Senaparib sales in China of RMB 70.4 million, up 877.8%; gross profit of RMB 95.5 million at a 90.8% gross margin; loss of RMB 90.8 million, narrowing 29.5%, and adjusted net loss of RMB 20.9 million, narrowing 62.6%; cash and financial assets totalled RMB 1,065.4 million as at 30 June 2026, and no interim dividend was declared.
